TiGenix

[TiGenix @tigenix]

There is a real need for new treatment options for the complications of #Crohns disease. TiGenix is committed to working to bring innovative new medicines to patients #WorldIBDDay

[TiGenix @tigenix]

At TiGenix, we are committed to helping patients suffering from severe and debilitating complications of #Crohns disease #IBD #WorldIBDDay

[TiGenix @tigenix]

TiGenix is proud to support #WorldIBDDay to raise awareness of #IBD #Crohns and #Colitis @CrohnsColitisUK

[TiGenix @tigenix]

I support #WorldIBDDay & the fight against #Crohns & #Colitis - add a #Twibbon now! https://t.co/pBkEGZ4FR6

[TiGenix @tigenix]

We are excited to be shortlisted for Breakthrough of the Year at the 2018 MediScience Awards @euroMed_Awards https://t.co/ZpZlQHveUs

[TiGenix @tigenix]

https://t.co/XE1foIrSuO

[TiGenix @tigenix]

Maria Pascual, VP Regulatory Affairs and Corporate Quality at TiGenix: “Today’s approval reflects our deep understanding and recognized leadership in the development of allogeneic stem cells and our firm commitment to developing innovative therapies for medical needs.” #crohns

[TiGenix @tigenix]

TiGenix and @TakedaPharma receive European approval for an allogeneic stem cell therapy to treat a complication of Crohn’s disease #crohns #IBD https://t.co/2cMTF3P97n

[TiGenix @tigenix]

[VIDEO] TiGenix focuses on the anti-inflammatory properties of adipose-derived stem cells to make new therapies. Discover how it works

https://t.co/VZqkYNyzg8 via @YouTube

[TiGenix @tigenix]

[VIDEO] Notre nouvelle vidéo d’entreprise est en ligne.
Partagez la bonne nouvelle!

https://t.co/rB7UJl4CQk via @YouTube

[TiGenix @tigenix]

[VIDEO] Onze nieuwe bedrijfsfilm staat online @tigenix
Deel het enthousiasme met ons!
https://t.co/2ES3UXPX8k via @YouTube

[TiGenix @tigenix]

[VIDEO] Nuestro nuevo video corporativo está online. Comparte nuestro entusiasmo!

https://t.co/Gr8TEmuN4I via @YouTube

[TiGenix @tigenix]

[VIDEO] Our new corporate video is online @tigenix
Share the excitement with us!

[TiGenix @tigenix]

REMINDER! Today, Monday 18th Dec at 15:00 CET, presentation on the CHMP opinion. Link to live webcast: https://t.co/uXdiSqZSX8

[TiGenix @tigenix]

Join us for webcast on the CHMP opinion via https://t.co/uXdiSqZSX8 on Monday 18th Dec at 15:00 CET https://t.co/RW5iQJ1HAL

[EU Medicines Agency @EMA_News]

New #AdvancedTherapy to treat perianal fistulas in patients with #CrohnsDisease: https://t.co/YThNsTWSiY #CHMP #ATMP

[TiGenix @tigenix]

-There is a real need for new treatment options for the complications of #Crohns disease. TiGenix is committed to working to bring innovative new medicines to patients #CCAwarenessWeek #IBD @CrohnsColitisFn

[TiGenix @tigenix]

-We are proud to support the Crohn’s & Colitis Foundation’s campaign to raise awareness of #Crohns and #Colitis #CCAwarenessWeek. #MakingTheInvisibleVisible #IBD @CrohnsColitisFn

[TiGenix @tigenix]

It’s #Crohns and #Colitis Awareness Week next week! TiGenix is proud to support the Crohn’s and Colitis Foundation’s efforts to raise awareness of #IBD #CCAwarenessWeek #MakingTheInvisibleVisible @CrohnsColitisFn

[TiGenix @tigenix]

Interesting debate today on Finance Avenue on the road to success in biotech sector @tigenix

[TiGenix @tigenix]

Today TiGenix presents @ Finance Avenue in Brussels @tigenix #cx601